Management of Clopidogrel in Patients Undergoing Surgery

Preoperative Discontinuation Timeline

The American College of Chest Physicians recommends stopping clopidogrel 5 days before elective non-cardiac surgery, unless the surgery involves a closed space, and maintaining aspirin throughout the perioperative period 1, 2
The standard recommendation is to discontinue clopidogrel 5 days (≤7 days maximum) before elective surgery to allow adequate platelet function recovery while minimizing thrombotic risk 1, 2

For patients with coronary stents, the thrombotic risk of stopping antiplatelet therapy can exceed the bleeding risk of continuing it, and high thrombotic risk patients should postpone elective surgery until 6-12 months after drug-eluting stent placement or 4-6 weeks after bare-metal stent 4, 5, 6, 3
The British Journal of Anaesthesia recommends maintaining aspirin and stopping clopidogrel 5 days before surgery for high thrombotic risk patients, and continuing both aspirin and clopidogrel for minor bleeding risk procedures 4, 5, 6, 8

For major bleeding risk surgeries, stop clopidogrel 5 days preoperatively and consider stopping aspirin in patients without stents, while maintaining aspirin in patients with stents whenever possible 4, 5, 6, 8
For intermediate bleeding risk surgeries, stop clopidogrel 5 days preoperatively and continue aspirin 4, 5
For minor bleeding risk surgeries, continue both aspirin and clopidogrel 4, 5, 8

Resume clopidogrel within 24 hours after surgery as soon as hemostasis is achieved, with a 300 mg loading dose recommended for high-risk patients 1, 2, 4, 5

For patients undergoing CABG surgery, stop clopidogrel 5 days before surgery, continue aspirin perioperatively, and resume both agents within 24 hours postoperatively 2, 11

Do not substitute clopidogrel with heparin or low-molecular-weight heparin as bridging therapy, as this does not protect against stent thrombosis and may increase bleeding risk 4, 5, 8, 7
Do not use platelet function testing routinely to guide perioperative management, as recommended by the 2022 CHEST guidelines 1, 2, 11

For complex cases, mandatory consultation between surgeon, anesthesiologist, and cardiologist is required to weigh thrombotic vs bleeding risks, and document the discussion and rationale in the medical record 4, 5, 6, 7